Literature DB >> 10988251

Carbohydrate groups of alpha1-microglobulin are important for secretion and tissue localization but not for immunological properties.

L Wester1, J Fast, T Labuda, T Cedervall, K Wingårdh, T Olofsson, B Akerström.   

Abstract

The role of the carbohydrates for the structure and functions of the plasma and tissue protein alpha1-microglobulin (alpha1m) was investigated by deletion of the sites for N-glycosylation by site-directed mutagenesis (N17,96-->Q). The mutated cDNA was expressed in a baculovirus-insect cell system resulting in a nonglycosylated protein. The biochemical properties of N17,96Q-alpha1m were compared to nonmutated alpha1m, which carries two short non-sialylated N-linked oligosaccharides when expressed in the same system. Both proteins carried a yellow-brown chromophore and were heterogeneous in charge. Circular dichroism spectra and antibody binding indicated a similar overall structure. However, the secretion of N17,96Q-alpha1m was significantly reduced and approximately 75% of the protein were found accumulated intracellularly. The in vitro immunological effects of recombinant nonmutated alpha1m and N17,96Q-alpha1m were compared to the effects of alpha1m isolated from plasma, which is sialylated and carries an additional O-linked oligosaccharide. All three alpha1m variants bound to human peripheral lymphocytes and mouse T cell hybridomas to the same extent. They also inhibited the antigen-stimulated proliferation of peripheral lymphocytes and antigen-stimulated interleukin 2-secretion of T cell hybridomas in a similar manner. After injection of rats intravenously, the blood clearance of recombinant nonmutated and N17,96Q-alpha1m was faster than that of plasma alpha1m. Nonmutated alpha1m was located primarily to the liver, most likely via binding to asialoglycoprotein receptors, and N17,96Q-alpha1m was located mainly to the kidneys. It is concluded that the carbohydrates of alpha1m are important for the secretion and the in vivo turnover of the protein, but not for the structure or immunological properties.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10988251     DOI: 10.1093/glycob/10.9.891

Source DB:  PubMed          Journal:  Glycobiology        ISSN: 0959-6658            Impact factor:   4.313


  6 in total

1.  Performance evaluation of developed polysulfone membrane hemodiafilters, ABH-F and ABH-P, in post- and pre-dilution hemodiafiltration.

Authors:  Ryoichi Sakiyama; Kenichiro Yamamoto; Isamu Ishimori; Satoshi Yoshida; Takashi Akiba; Michio Mineshima
Journal:  J Artif Organs       Date:  2015-06-10       Impact factor: 1.731

2.  Oxalate-inducible AMBP gene and its regulatory mechanism in renal tubular epithelial cells.

Authors:  Jasjit S Grewal; Jeng Y Tsai; Saeed R Khan
Journal:  Biochem J       Date:  2005-05-01       Impact factor: 3.857

3.  177Lu-PSMA-617 Therapy in Mice, with or without the Antioxidant α1-Microglobulin (A1M), Including Kidney Damage Assessment Using 99mTc-MAG3 Imaging.

Authors:  Amanda Kristiansson; Anders Örbom; Jonas Ahlstedt; Helena Karlsson; Wahed Zedan; Magnus Gram; Bo Åkerström; Sven-Erik Strand; Mohamed Altai; Joanna Strand; Oskar Vilhelmsson Timmermand
Journal:  Biomolecules       Date:  2021-02-10

4.  Ferryl Hemoglobin and Heme Induce A1-Microglobulin in Hemorrhaged Atherosclerotic Lesions with Inhibitory Function against Hemoglobin and Lipid Oxidation.

Authors:  Dávid Pethő; Tamás Gáll; Zoltán Hendrik; Annamária Nagy; Lívia Beke; Attila Péter Gergely; Gábor Méhes; Csaba Tóth; Magnus Gram; Bo Åkerström; György Balla; József Balla
Journal:  Int J Mol Sci       Date:  2021-06-22       Impact factor: 5.923

5.  rA1M-035, a Physicochemically Improved Human Recombinant α1-Microglobulin, Has Therapeutic Effects in Rhabdomyolysis-Induced Acute Kidney Injury.

Authors:  Bo Åkerström; Lena Rosenlöf; Anneli Hägerwall; Sigurbjörg Rutardottir; Jonas Ahlstedt; Maria E Johansson; Lena Erlandsson; Maria Allhorn; Magnus Gram
Journal:  Antioxid Redox Signal       Date:  2018-04-11       Impact factor: 8.401

Review 6.  The Role of α1-Microglobulin (A1M) in Erythropoiesis and Erythrocyte Homeostasis-Therapeutic Opportunities in Hemolytic Conditions.

Authors:  Amanda Kristiansson; Magnus Gram; Johan Flygare; Stefan R Hansson; Bo Åkerström; Jill R Storry
Journal:  Int J Mol Sci       Date:  2020-09-30       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.